Literature DB >> 21607779

Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Enrica De Rosa1, Ciro Chiappini, Dongmei Fan, Xuewu Liu, Mauro Ferrari, Ennio Tasciotti.   

Abstract

PURPOSE: Protein therapeutics often require repeated administrations of drug over a long period of time. Protein instability is a major obstacle to the development of systems for their controlled and sustained release. We describe a surface modification of nanoporous silicon particles (NSP) with an agarose hydrogel matrix that enhances their ability to load and release proteins, influencing intracellular delivery and preserving molecular stability.
METHODS: We developed and characterized an agarose surface modification of NSP. Stability of the released protein after enzymatic treatment of loaded particles was evaluated with SDS-page and HPLC analysis. FITC-conjugated BSA was chosen as probe protein and intracellular delivery evaluated by fluorescence microscopy.
RESULTS: We showed that agarose coating does not affect NSP protein release rate, while fewer digestion products were found in the released solution after all the enzymatic treatments. Confocal images show that the hydrogel coating improves intracellular delivery, specifically within the nucleus, without affecting the internalization process.
CONCLUSIONS: This modification of porous silicon adds to its tunability, biocompatibility, and biodegradability the ability to preserve protein integrity during delivery without affecting release rates and internalization dynamics. Moreover, it may allow the silicon particles to function as protein carriers that enable control of cell function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607779     DOI: 10.1007/s11095-011-0453-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Growth hormone as an immunomodulating therapeutic agent.

Authors:  W J Murphy; D L Longo
Journal:  Immunol Today       Date:  2000-05

3.  Controlled growth factor delivery for tissue engineering.

Authors:  Prakriti Tayalia; David J Mooney
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

Review 4.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 5.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

6.  Nanogeometry: beyond drug delivery.

Authors:  Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03       Impact factor: 39.213

7.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Authors:  Ennio Tasciotti; Xuewu Liu; Rohan Bhavane; Kevin Plant; Ashley D Leonard; B Katherine Price; Mark Ming-Cheng Cheng; Paolo Decuzzi; James M Tour; Fredika Robertson; Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

8.  Cellular association and assembly of a multistage delivery system.

Authors:  Rita E Serda; Aaron Mack; Merlyn Pulikkathara; Ana Maria Zaske; Ciro Chiappini; Jean R Fakhoury; Douglas Webb; Biana Godin; Jodie L Conyers; Xue W Liu; James A Bankson; Mauro Ferrari
Journal:  Small       Date:  2010-06-21       Impact factor: 13.281

9.  Tailored porous silicon microparticles: fabrication and properties.

Authors:  Ciro Chiappini; Ennio Tasciotti; Jean R Fakhoury; Daniel Fine; Lee Pullan; Young-Chung Wang; Lianfeng Fu; Xuewu Liu; Mauro Ferrari
Journal:  Chemphyschem       Date:  2010-04-06       Impact factor: 3.102

10.  Enzyme replacement therapy for primary adult lactase deficiency. Effective reduction of lactose malabsorption and milk intolerance by direct addition of beta-galactosidase to milk at mealtime.

Authors:  J L Rosado; N W Solomons; R Lisker; H Bourges
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

View more
  10 in total

1.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

2.  Multiscale patterning of a biomimetic scaffold integrated with composite microspheres.

Authors:  Silvia Minardi; Monica Sandri; Jonathan O Martinez; Iman K Yazdi; Xeuwu Liu; Mauro Ferrari; Bradley K Weiner; Anna Tampieri; Ennio Tasciotti
Journal:  Small       Date:  2014-05-28       Impact factor: 13.281

3.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

Review 4.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

5.  The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Vivek Karun; Evan Shegog; Joshua A Wang; Christian Boada; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

6.  Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.

Authors:  Iman K Yazdi; Matthew B Murphy; Christopher Loo; Xuewu Liu; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2014-05-19       Impact factor: 7.813

7.  A simple approach for preparation of affinity matrices: Simultaneous purification and reversible immobilization of a streptavidin mutein to agarose matrix.

Authors:  Sau-Ching Wu; Chris Wang; Dave Hansen; Sui-Lam Wong
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 8.  Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy.

Authors:  Anna Pasto; Federica Giordano; Michael Evangelopoulos; Alberto Amadori; Ennio Tasciotti
Journal:  Clin Transl Med       Date:  2019-03-15

9.  Biocompatible PLGA-Mesoporous Silicon Microspheres for the Controlled Release of BMP-2 for Bone Augmentation.

Authors:  Silvia Minardi; Joseph S Fernandez-Moure; Dongmei Fan; Matthew B Murphy; Iman K Yazdi; Xuewu Liu; Bradley K Weiner; Ennio Tasciotti
Journal:  Pharmaceutics       Date:  2020-02-01       Impact factor: 6.321

10.  Composite microsphere-functionalized scaffold for the controlled release of small molecules in tissue engineering.

Authors:  Laura Pandolfi; Silvia Minardi; Francesca Taraballi; Xeuwu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2016-01-11       Impact factor: 7.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.